Association of FSH with metabolic syndrome in postmenopausal women: A comparison with CRP, adiponectin and leptin

Biomarkers in Medicine

Volumn 8, Issue 7, 2014, Pages 921-930

  Stefanska, Anna ^a   Ponikowska, Irena ^b   Cwiklinska Jurkowska, Malgorzata ^a   Sypniewska, Grazyna ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

adiponectin; C reactive protein; follicle stimulating hormone; leptin; menopause; metabolic syndrome

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ESTRADIOL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EVALUATION STUDY; FEMALE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LEPTIN TO ADIPONECTIN RATIO; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; METABOLIC SYNDROME X; OBESITY; POSTMENOPAUSE; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRIGLYCERIDE HIGH DENSITY LIPOPROTEIN CHOLESTEROL RATIO; WAIST CIRCUMFERENCE; BLOOD; DIAGNOSTIC USE; METABOLISM; MIDDLE AGED;

ADIPONECTIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LEPTIN; METABOLIC SYNDROME X; MIDDLE AGED; POSTMENOPAUSE;

EID: 84907924745     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.14.49     Document Type: Article

References (33)

1. Dandona P, Dhindsa S. Update: hypogonadotropic hypogonadism in Type 2 diabetes and obesity. J. Clin. Endocrinol. Metab. 96, 2643-2651 (2011).
2. Castelo-Branco C, Steinvarcel F, Osorio A, Ros C, Balasch J. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism. Gynecol. Endocrinol. 26, 736-742 (2010).
3. Turcato E, Zamboni M, De Pergola G, et al. Interrelationships between weight loss, body fat distribution and sex hormones in pre-And postmenopausal obese women. J. Intern. Med. 241, 363-372 (1997
4. Bjørnerem A, Straume B, Midtby M, et al. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromsø Study. J. Clin. Endocrinol. Metab. 89, 6039-6047 (2004).
5. Malacara JM, Fajardo ME, Nava LE. Gonadotropins at menopause: the influence of obesity, insulin resistance, and estrogens. Steroids 66, 559-567 (2001).
6. Stefanska A, Sypniewska G, Ponikowska I, Cwiklinska-Jurkowska M. Association of follicle-stimulating hormone and sex hormone binding globulin with the metabolic syndrome in postmenopausal women. Clin. Biochem. 45, 703-706 (2012).
7. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645 (2009).
8. Marx TL, Mehta AE. Polycystic ovary syndrome: pathogenesis and treatment over the short and long term. Cleve. Clin. J. Med. 70, 31-45 (2003).
9. Banaszewska B, Spaczynski RZ, Pelesz M, Pawelczyk L. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo-And hyperinsulinemia. Rocz. Akad. Med. Bialymst. 48, 131-134 (2003).
10. Dandona P, Dhindsa S. Update: hypogonadotropic hypogonadism in Type 2 diabetes and obesity. J. Clin. Endocrinol. Metab. 96, 2643-2651 (2011).
11. Lee CC, Kasa-Vubu JZ, Supiano MA. Androgenicity and obesity are independently associated with insulin sensitivity in postmenopausal women. Metabolism 53, 507-512 (2004).
12. Ding EL, Song Y, Manson JE, et al. Plasma sex steroid hormones and risk of developing Type 2 diabetes in women: a prospective study. Diabetologia 50, 2076-2084 (2007).
13. Ding EL, Song Y, Malik VS, Liu. S. Sex differences of endogenous sex hormones and risk of Type 2 diabetes: a systematic review and meta-Analysis. JAMA 295, 1288-1299 (2006).
14. Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog. Horm. Res. 57, 257-275 (2002).
15. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J. Clin. Endocrinol. Metab. 97, 1159-1168 (2012).
16. Randolph JF Jr, Zheng H, Sowers MR, et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J. Clin. Endocrinol. Metab. 96, 746-754 (2011).
17. The IDF worldwide definition of the metabolic syndrome. www.idf.org/metabolic-syndrome
18. Zhuo Q, Wang Z, Fu P, et al. Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities. Diabetes Res. Clin. Pract. 84, 27-33 (2009).
19. Cicero AF, Magni P, Moré M, et al. Heart Study Staff. Metabolic syndrome, adipokines and hormonal factors in pharmacologically untreated adult elderly subjects from the Brisighella Heart Study historical cohort. Obes. Facts 5, 319-326 (2012).
20. Freeman EW, Sammel MD, Lin H, Gracia CR. Obesity and reproductive hormone levels in the transition to menopause. Menopause 17, 718-726 (2010).
21. Velasco E, Malacara JM, Cervantes F, de Leà n JD, Dávalos G, Castillo J. Gonadotropins and prolactin serum levels during the perimenopausal period: correlation with diverse factors. Fertil. Steril. 53, 56-60 (1990).
22. Beydoun HA, Beydoun MA, Wiggins N, Stadtmauer L. Relationship of obesity-related disturbances with LH/FSH ratio among post-menopausal women in the United States. Maturitas 71, 55-61 (2012).
23. Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J. Natl Cancer. Inst. 95, 1218-1226 (2003).
24. Mahabir S, Baer DJ, Johnson LL, et al. Usefulness of body mass index as a sufficient adiposity measurement for sex hormone concentration associations in postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 15, 2502-2507 (2006).
25. Liedtke S, Schmidt ME, Vrieling A, et al. Postmenopausal sex hormones in relation to body fat distribution. Obesity (Silver Spring) 20, 1088-1095 (2012).
26. Randolph Jr. JF, Sowers MF, Gold EB, et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J. Clin. Endocrinol. Metab. 88, 1516-1522 (2003).
27. de Ronde W, Hofman A, Pols HA, de Jong FH. A direct approach to the estimation of the origin of oestrogens and androgens in elderly men by comparison with hormone levels in postmenopausal women. Eur. J. Endocrinol. 152, 261-268 (2005).
28. Ding EL, Song Y, Manson JE, Rifai N, Buring JE, Liu S. Plasma sex steroid hormones and risk of developing Type 2 diabetes in women: a prospective study. Diabetologia 50, 2076-2084 (2007).
29. Karim R, Mack WJ, Hodis HN, Roy S, Stanczyk FZ. Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal women. J. Clin. Endocrinol. Metab. 94, 4136-4143 (2009
30. García-Martín A, Reyes-García R, García-Castro JM, et al. Gonadotropins are related to lean mass in healthy postmenopausal women. Endocr. Res. 38, 119-124 (2013).
31. Santoro N, Lasley Bill, McConnell Dan, et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: the study of Women's Health across the Nation (SWAN) daily hormone study. J. Clin. Endocrinol. Metab. 89, 2622-2631 (2004).
32. De Pergola G, Maldera S, Tartagni M, Pannacciulli N, Loverro G, Giorgino R. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women. Obesity (Silver Spring) 14, 1954-1960 (2006).
33. Grenman S, Rönnemaa T, Irjala K, Kaihola HL, Grönroos M. Sex steroid, gonadotropin, cortisol, and prolactin levels in healthy, massively obese women: correlation with abdominal fat cell size and effect of weight reduction. J. Clin. Endocrinol. Metab. 63, 1257-1261 (1986